Home / News Article

Association for Treatment of Neuroplastic Symptoms Launches with Focus on Chronic Pain and Illness

Charity Ace News - Business and Technology News October 29, 2024
By Charity Ace News Staff
Read Original Article →
Association for Treatment of Neuroplastic Symptoms Launches with Focus on Chronic Pain and Illness

Summary

The rebranding of the Psychophysiologic Disorders Association to the Association for Treatment of Neuroplastic Symptoms (ATNS) signifies a pivotal shift towards addressing chronic pain and illness through the lens of neuroplasticity, offering new hope for millions affected by these conditions.

Full Article

The Association for Treatment of Neuroplastic Symptoms (ATNS), formerly known as the Psychophysiologic Disorders Association, has embarked on a transformative journey to redefine the approach to chronic pain and illness. By centering its mission around the concept of neuroplasticity—the brain's remarkable ability to adapt and heal—ATNS is pioneering a scientific and evidence-based methodology to treat conditions that have long baffled both patients and practitioners.

Neuroplastic symptoms, which include chronic primary pain, migraines, fibromyalgia, irritable bowel syndrome, and post-viral syndromes, are generated by the brain in response to stress, rather than by structural damage or disease. This understanding marks a paradigm shift in the medical community's approach to chronic conditions, emphasizing the need for treatments that address the root causes of pain and illness, rather than merely managing symptoms.

With an estimated 1.5 billion people worldwide suffering from chronic pain or illness not caused by disease or injury, the implications of ATNS's work are profound. The organization's focus on education, research, and advocacy aims to empower both practitioners and patients with knowledge and tools to tackle these conditions more effectively. By fostering interdisciplinary collaboration and advocating for policy changes, ATNS is setting the stage for a more compassionate and effective healthcare response to neuroplastic symptoms.

The rebranding to ATNS and the adoption of the new brand, Symptomatic, reflect the organization's commitment to growth, empowerment, and transformation. This new chapter not only signifies a fresh identity but also a renewed dedication to improving the lives of those affected by neuroplastic symptoms. As the medical community continues to embrace this innovative approach, the potential for more accurate diagnoses and effective treatments offers a beacon of hope for millions seeking relief from chronic pain and illness.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at 24-7 Press Release